Humankind Investments LLC Trims Holdings in HCA Healthcare, Inc. $HCA

Humankind Investments LLC lessened its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 42.1% during the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 2,724 shares of the company’s stock after selling 1,980 shares during the period. Humankind Investments LLC’s holdings in HCA Healthcare were worth $1,044,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Saudi Central Bank acquired a new stake in shares of HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC purchased a new stake in HCA Healthcare in the first quarter valued at $27,000. Ameriflex Group Inc. purchased a new position in shares of HCA Healthcare during the 2nd quarter worth $27,000. Chung Wu Investment Group LLC purchased a new stake in HCA Healthcare in the 2nd quarter valued at about $27,000. Finally, Clearstead Trust LLC increased its position in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Performance

HCA stock opened at $484.67 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $520.00. The firm has a market capitalization of $110.60 billion, a price-to-earnings ratio of 18.73, a PEG ratio of 1.42 and a beta of 1.36. The company’s 50 day moving average price is $465.59 and its 200 day moving average price is $413.62.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the stock. Zacks Research downgraded shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $412.00 to $431.00 and gave the company an “equal weight” rating in a report on Thursday, November 13th. Robert W. Baird lifted their target price on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research report on Thursday. Sanford C. Bernstein reissued a “market perform” rating and issued a $417.00 price objective on shares of HCA Healthcare in a research note on Monday, October 27th. Finally, Oppenheimer increased their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday, October 27th. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $475.95.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the stock in a transaction that occurred on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. This represents a 52.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.30% of the stock is owned by company insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.